How to Edit Organoids Without Disrupting Their Structure

Three approaches, in order of structural preservation:

1. Edit before organoid formation — dissociate to single cells, edit by RNP electroporation, re-aggregate. Structure is lost for days, not weeks, and reforms.
2. Edit established organoids by microinjection or viral transduction — preserves architecture but gives mosaic editing.
3. Edit, select, and re-derive — the most controlled and the most disruptive.

The choice turns on whether you need clonality or architecture more. You rarely get both.

Workflow. Dissociate organoids to single cells; electroporate RNP; re-aggregate at defined density; allow re-formation; validate editing in the resulting organoids.

Advantages. Editing efficiency is highest at the single-cell stage; re-aggregation is a standard protocol step; structure reforms within days for most epithelial systems.

Caveats. Re-aggregation efficiency varies by tissue; the resulting organoids are usually mosaic unless selection is applied; and the dissociation step itself can select for cells with different growth properties — a bias that persists.

Workflow. Transduce with lentivirus or apply RNP electroporation under matrix-preserving conditions; do not dissociate.

Advantages. Architecture persists throughout the experiment.

Caveats. Editing is mosaic and often low-efficiency; access to the interior of large organoids is limited; and selection is difficult without disturbing structure. Suitable for questions where a subpopulation of edited cells is sufficient — for example, lineage tracing or a cell-autonomous reporter.

Workflow. Edit at the single-cell stage, apply selection (drug resistance or sorting on a reporter), re-aggregate selected cells, and, where required, derive clonal organoids.

Advantages. The only route to a clean, clonal edited organoid line.

Caveats. Slowest; clonal derivation from single cells is inefficient for many tissues; and clone-specific growth differences appear at the organoid level as well.

• • Dissociate gently and count accurately. Viability after dissociation predicts re-aggregation success more than editing efficiency does.
• • Match matrix and medium to the re-aggregation step, not to the expansion step; they are often different.
• • Report mosaicism. If editing was done in-organoid, quantify the fraction of edited cells, or the result is uninterpretable.
• • Choose readouts that tolerate heterogeneity — per-organoid imaging, secretion, single-cell profiling — rather than bulk lysis.
• • Include unedited organoids from the same batch as controls, since batch effects dominate many comparisons.

EDITGENE builds organoid editing workflows with single-cell RNP delivery, documented re-aggregation efficiency, mosaicism quantification, and per-organoid readouts.

Tell us the tissue and the edit. Contact EDITGENE to request a project consultation or quote.

Dissociation and re-aggregation can select for subpopulations; comparisons should use organoids that underwent the same process, including unedited controls.

Editing efficiency and mosaicism vary by tissue and protocol and should be quantified rather than assumed.

• • Drost J, Clevers H. Organoids in cancer research. Nature Reviews Cancer. 2018;18:407–418.
• • Kim J, Koo BK, Knoblich JA. Human organoids: model systems for human biology and medicine. Nature Reviews Molecular Cell Biology. 2020;21:571–584.
• • Artegiani B, et al. Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing. Nature Cell Biology. 2020;22:321–331.